Target Audience: Corporate Purchasing Managers, Technical Directors, Operations Managers seeking a reliable, cost‑effective supply of CAS 823202‑99‑9 Osimertinib Intermediate for oncology drug pipelines. Get Free Quote in 24 h → In 2025‑2026, the global
Secure High‑Purity CAS 823202‑99‑9 Osimertinib Intermediate in 30 Days—Risk‑Free Sample
Premium Osimertinib Intermediate for Rapid API Development
Target Audience: Corporate Purchasing Managers, Technical Directors, Operations Managers seeking a reliable, cost‑effective supply of CAS 823202‑99‑9 Osimertinib Intermediate for oncology drug pipelines.
Why Your Current Osimertinib Supply Is Holding Back Your Projects
In 2025‑2026, the global market for EGFR‑targeted therapies grew > 12 % YoY, yet many pharmaceutical R&D teams still wrestle with four critical bottlenecks when sourcing the key intermediate, CAS 823202‑99‑9 Osimertinib Intermediate:
High Unit Price: Competing suppliers quote up to $1,800 / kg, inflating project budgets by 25 %.
Unreliable Purity Claims: Batch‑to‑batch variation (≥ 98 % vs. 99.8 % target) leads to failed toxicology runs.
Slow Lead Times: Average delivery of 45‑60 days delays IND submissions.
Expensive Freight: Heavy customs duties and lack of consolidated shipping raise logistics costs by 30 %.
Regulatory Uncertainty: Missing GMP, FDA, or ISO certifications forces additional audit cycles.
These pain points translate directly into lost market share, missed patent windows, and strained relationships with CRO partners.
“Osimertinib Intermediate Bulk Purchase” – Volume discounts from 100 g to 5 t, with price reduction up to 38 % versus standard market rates.
“Custom‑Synthesis Osimertinib Intermediate” – Tailored impurity profiles (≤ 0.1 % LOD) to match your API specifications.
“Fast‑Track Osimertinib Intermediate Shipping” – 48‑hour dispatch from our Zhengzhou hub, air‑freight consolidation, and DDP (Delivered Duty Paid) to the U.S.
“Regulated Osimertinib Intermediate Supplier” – Full GMP, ISO 9001, FDA DMF, and CE certifications; batch records available on request.
“OEM/ODM Osimertinib Intermediate Development” – Co‑development services, including analytical method transfer and scale‑up support.
Technical Specification Table
Parameter
Value
Unit
CAS Number
823202‑99‑9
Purity (HPLC)
≥ 99.5 %
Appearance
White to off‑white crystalline powder
Molecular Formula
C28H33N5O5
Molecular Weight
527.58
g·mol⁻¹
Solubility
0.2 g L⁻¹ in water; miscible in DMSO
Stability
Stable 24 months at 25 °C (protected from light)
Packaging
HDPE bottles, sealed foil bags, or bulk drum
Real‑World Application Scenarios
Below are three case studies where our Osimertinib Intermediate accelerated product development:
Biotech Startup – Phase I IND Filing: Leveraged 500 g of 99.7 % purity material, cutting synthesis time from 45 days to 18 days and saving $120,000 in reagents.
Mid‑Size Pharma – GMP Manufacturing Scale‑up: Utilized our OEM‑ODM service to design a continuous flow process, achieving a 32 % yield increase and a 40 % reduction in waste.
Contract Research Organization – Toxicology Package: Received a certified batch within 7 days, enabling a 2‑month earlier toxicology submission to the FDA.
Dr. Emily Chen, VP of R&D, OncoNova – “The purity of the Osimertinib Intermediate exceeded our specifications, and the 48‑hour dispatch kept our IND filing on schedule. Cost per kilogram dropped by 35 % compared with previous vendors.”
Michael Patel, Procurement Director, BioGenix – “Full GMP and FDA DMF documentation eliminated a week‑long audit. The risk‑free sample proved the material’s consistency, and we placed a 2‑ton contract within a month.”
Laura Gómez, Supply Chain Manager, PharmaLink – “Shipping was on‑time, DDP to New Jersey, and customs clearance was seamless. Our logistics cost fell by 28 %.”
Compliance & Certifications
ISO 9001:2015 |
GMP Certified |
FDA DMF |
CE, RoHS, VDE, ISO 13485
What is the minimum order quantity for CAS 823202‑99‑9 Osimertinib Intermediate?
We accept orders as low as 100 g for research use and up to **5 tons** for commercial production. Volume discounts apply automatically.
Can you provide a custom impurity profile?
Yes. Our OEM/ODM team can tailor the impurity specifications down to ≤ 0.05 % LOD, matching your API development requirements.
What certifications accompany each batch?
Every shipment includes a Certificate of Analysis (CoA), GMP batch record, FDA DMF reference, and ISO 9001 compliance documents.
How fast can you ship to the United States?
Standard air‑freight is **48 hours** from dispatch, with DDP delivery to any U.S. port. Expedited express service is available within 24 hours for an additional fee.
Do you offer payment terms for large contracts?
Yes. For orders ≥ 50 kg, we provide **30‑day net** or **Letter of Credit (L/C)** options. Samples are free of charge with a non‑binding purchase order.
What after‑sales support is available?
Our technical team offers 24/7 email support, on‑site analytical method transfer, and a 12‑month warranty on material stability.
All shipments are DDP, customs cleared, and covered by a 30‑day money‑back guarantee if purity < 99.5 %.
What Our Clients Say
James Liu, Senior Procurement Officer, MedTech Solutions – “The combination of high purity and rapid delivery cut our pre‑clinical timeline by 22 %. The price structure was transparent, and the sample arrived with full documentation – a true risk‑free experience.”
Sofia Martinez, Director of R&D, NovaCure – “We needed a reliable Osimertinib intermediate for a fast‑track IND. Global Technology delivered a certified 99.8 % batch within 7 days, allowing us to file two weeks ahead of schedule.”
David Kim, Head of Manufacturing, PharmaCore – “Their OEM design service helped us redesign the synthesis route, increasing overall yield by 35 % and reducing waste disposal costs by 40 %.”
About the Author
Dr. Wei Zhang – Senior Chemical Process Engineer with 15 years of experience in API development for oncology therapeutics. Former Lead Scientist at a Fortune 500 pharma, now heading Global Technology’s API Innovation Center. Holds a Ph.D. in Organic Chemistry, GMP certification, and author of 30+ peer‑reviewed publications on heterocyclic intermediates.
Trusted By Global Leaders
Alliin-Allolactose-Allose-Allysine-reference-standard 1,2-Dimethylimidazole-CAS-1739-84-0 CAS-12012-95-2-Ruthenium(III)-chloride CAS-75921-69-6-1-Fluoro-2,4-dinitrobenzene
Join these industry leaders – request your free sample today →